Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afimetoran in active Systemic Lupus Erythematosus
NCT04895696Phase 2Active, not recruiting
- Sponsor
- Beeline Medicines
- Start
- Oct 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of afimetoran in systemic lupus erythematosus (SLE), sponsored by Beeline Medicines. Started Oct 2021; status: active, not recruiting.
02
Drugs
afimetoran
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04895696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895696.